Refining accuracy of RV–PA coupling in patients undergoing transcatheter tricuspid valve treatment
Authors:
Open Access
- 27 November 2023
- journal article
- research article
- Published by Springer Nature in Clinical Research in Cardiology
- Vol. 113 (1) , 177-186
Abstract
Background: Assessing right ventricular (RV) function is paramount for risk stratification, which remains challenging in patients with tricuspid regurgitation (TR). We assessed RV–pulmonary artery (PA) coupling and its predictability of outcomes after transcatheter tricuspid valve repair (TTVR). Methods: Study participants comprised patients undergoing transcatheter tricuspid valve repair to treat symptomatic TR from June 2015 to July 2021. We calculated an RV–PA coupling ratio using a formula, which is dividing tricuspid annular plane systolic excursion (TAPSE) by echocardiographically estimated (ePASP) or invasively measured PASP (iPASP) at baseline. The primary outcome was all-cause mortality or heart failure rehospitalization within one year. Results: The study participants (n = 206) were at high surgical risk (EuroSCORE II: 7.4 ± 4.8%). The primary outcome occurred in 57 patients within one year. The c-statistics for the outcome were 0.565 (95% CI 0.488–0.643) for TAPSE/ePASP and 0.695 (95% CI 0.631–0.759) for TAPSE/iPASP. The correlation between the ePASP and iPASP was attenuated in patients with massive/torrential TR compared to those with severe TR (interaction p = 0.01). In the multivariable Cox proportional model, TAPSE/iPASP was inversely associated with the risk of the primary outcome (per 0.1-point increase: adjusted-HR 0.67, 95% CI 0.56–0.82, p < 0.001), independent of baseline demographics. According to the TAPSE/iPASP quartiles (i.e., ≤ 0.316; 0.317–0.407; 0.408–0.526; ≥ 0.527), the event-free survival was 43.4%, 48.3%, 77.9%, and 85.4% at one year after TTVR. Conclusion: RV–PA coupling predicts one-year mortality and heart failure rehospitalization after TTVR in patients with TR. The predictability is improved if invasively-measured PA pressure is included. Graphical Assessing right ventricular (RV) function is paramount for risk stratification. The present analysis confirms that RV–PA coupling, measured as TAPSE/PASP, predicts one-year mortality and heart failure rehospitalization in patients undergoing TTVR. There is a significant interaction between TR severity and the correlation of ePASP with iPASP, and therefore the correlation is attenuated in patients with massive to torrential TR. The predictability of RV–PA coupling is improved if PA pressure is measured invasively and included in the formula.Keywords
Funding Information
- Universitätsklinikum Bonn
This publication has 20 references indexed in Scilit:
- 2020 ACC/AHA guideline for the management of patients with valvular heart diseaseThe Journal of Thoracic and Cardiovascular Surgery, 2021
- Prognostic impact of hepatorenal function in patients undergoing transcatheter tricuspid valve repairScientific Reports, 2021
- Outcomes of transcatheter tricuspid valve intervention by right ventricular function: a multicentre propensity-matched analysisEuroIntervention, 2021
- Hypofractionated and single-fraction radiosurgery for brain metastases with sex as a key predictor of overall survivalScientific Reports, 2021
- Transcatheter Edge-to-Edge Repair for Treatment of Tricuspid RegurgitationJACC, 2021
- Early Feasibility Study of Cardioband Tricuspid System for Functional Tricuspid RegurgitationJACC: Cardiovascular Interventions, 2021
- Hypofractionated and single-fraction radiosurgery for brain metastases with sex as a key predictor of overall survivalResearch Square, 2020
- Clinical characteristics, diagnosis, and risk stratification of pulmonary hypertension in severe tricuspid regurgitation and implications for transcatheter tricuspid valve repairEuropean Heart Journal, 2020
- Transcatheter edge-to-edge repair for reduction of tricuspid regurgitation: 6-month outcomes of the TRILUMINATE single-arm studyThe Lancet, 2019
- 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertensionEuropean Heart Journal, 2015